PT - JOURNAL ARTICLE AU - L Alvarez AU - R Macias AU - N Pavón AU - G López AU - M C Rodríguez-Oroz AU - R Rodríguez AU - M Alvarez AU - I Pedroso AU - J Teijeiro AU - R Fernández AU - E Casabona AU - S Salazar AU - C Maragoto AU - M Carballo AU - I García AU - J Guridi AU - J L Juncos AU - M R DeLong AU - J A Obeso TI - Therapeutic efficacy of unilateral subthalamotomy in Parkinson’s disease: results in 89 patients followed for up to 36 months AID - 10.1136/jnnp.2008.154948 DP - 2009 Sep 01 TA - Journal of Neurology, Neurosurgery & Psychiatry PG - 979--985 VI - 80 IP - 9 4099 - http://jnnp.bmj.com/content/80/9/979.short 4100 - http://jnnp.bmj.com/content/80/9/979.full SO - J Neurol Neurosurg Psychiatry2009 Sep 01; 80 AB - Background: Stereotactic thermocoagulative lesions of the subthalamic nucleus (STN) have been shown to induce significant motor improvement in patients with Parkinson’s disease (PD).Patients and methods: 89 patients with PD were treated with unilateral subthalamotomy. 68 patients were available for evaluations after 12 months, 36 at 24 months and 25 at 36 months.Results: The Unified Parkinson’s Disease Rating Scale (UPDRS) motor scores improved significantly contralaterally to the lesion in the “off” and “on” states throughout the follow-up, except for the “on” state at the last evaluation. Axial features and signs ipsilateral to the lesion progressed steadily throughout the study. Levodopa daily doses were significantly reduced by 45%, 36% and 28% at 12, 24 and 36 months post-surgery. 14 patients (15%) developed postoperative hemichorea-ballism which required pallidotomy in eight. These 14 patients had significantly higher dyskinesia scores (levodopa induced) preoperatively than the entire cohort.Conclusion: Unilateral subthalamotomy was associated with significant and sustained motor benefit contralateral to the lesion. Further work is needed to ascertain what factors led to severe, persistent chorea-ballism in a subset of patients. Subthalamotomy may be considered an option in circumstances when deep brain stimulation is not viable.